Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-25 @ 12:01 AM
Ignite Modification Date:
2025-12-25 @ 9:59 PM
NCT ID:
NCT04358458
Pre Assignment Details:
This study was to be conducted in 2 parts; Part 1 was the dose-escalation phase and Part 2 was the expansion phase. However, the trial was terminated due to strategic evaluation of GEN3009 within context of Genmab's portfolio, the sponsor decided not to conduct the expansion phase (Part 2).
Recruitment Details:
The study was conducted at investigative sites in Belgium, Denmark, France, Spain and the United States from 13 March 2020 to 28 July 2023.
Study:
NCT04358458
Study Brief:
Results Section:
NCT04358458